It seems the institutions are trying to bring their average price down as most of the stocks they have been buying have been underperformers and more importantly, the outlook does not give many reasons for a fresh buy, independent market expert Ambareesh Baliga told ETMarkets.com.
Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellers
Dr Agarwals Health Care shares dropped on Wednesday after a Rs 2,065-crore block deal involving 4.07 crore shares. Hyperion Investments and Claymore Investments were likely